Garen Z. Manvelian
Technik-/Wissenschafts-/F&E-Leiter bei New River Pharmaceuticals, Inc.
Aktive Positionen von Garen Z. Manvelian
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Technik-/Wissenschafts-/F&E-Leiter | 09.10.2006 | - |
Karriereverlauf von Garen Z. Manvelian
Ehemalige bekannte Positionen von Garen Z. Manvelian
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Quintiles CNS Therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - | - |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Technik-/Wissenschafts-/F&E-Leiter | 15.12.2009 | - |
Ausbildung von Garen Z. Manvelian
Vitebsk State Medical University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Weißrussland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |
Quintiles CNS Therapeutics |
- Börse
- Insiders
- Garen Z. Manvelian
- Erfahrung